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Obesity during pregnancy has a long-term effect on the health of the offspring including risk of
developing the metabolic syndrome. Using a mouse model of maternal diet-induced obesity, we
employed a genome-wide approach to investigate the microRNA (miRNA) and miRNA transcrip-
tion profile in adipose tissue to understandmechanisms throughwhich this occurs. Male offspring
of diet-induced obese mothers, fed a control diet from weaning, showed no differences in body
weight or adiposity at 8 weeks of age. However, offspring from the obese dams had up-regulated
cytokine (Tnf; P .05) and chemokine (Ccl2 andCcl7; P .05) signaling in their adipose tissue. This
wasaccompaniedbyreducedexpressionofmiR-706,whichweshowedcandirectlyregulatetranslation
of the inflammatory proteins IL-33 (41% up-regulated; P  .05) and calcium/calmodulin-dependent
protein kinase 1D (30% up-regulated; P  .01). We conclude that exposure to obesity during devel-
opment primes an inflammatory environment in adipose tissue that is independent of offspring adi-
posity. Programming of adipose tissue miRNAs that regulate expression of inflammatory signaling
molecules may be a contributing mechanism. (Endocrinology 157: 4246–4256, 2016)
Over recent years, there has been analarming rise in theprevalence of obesity inWestern populations includ-
ing women of childbearing age (1, 2). This is of concern as
obesity during pregnancy is associated with detrimental
outcomes for both mother and child, including increased
risk of preeclampsia and complicated delivery (3). As well
as these immediate detrimental consequences, it is also
thought that obesity during pregnancy has long-term effects
on the health of the offspring as a consequence of “develop-
mental programming.”This is based on the notion that con-
ditions presented during critical windows of development
lead to permanent programmed alterations in physiological
systems and consequently organ function and whole-body
metabolism (4). Although initial studies in this field focused
on fetal undernutrition/low birth weight and increased risk
of heart disease (5) and glucose intolerance/type 2 diabetes
(6), in light of the current obesity epidemic there is now a
growing focus on the detrimental effects of overnutrition
during pregnancy (reviewed in Ref. 7).
In humans, the strongest evidence for the programming
effects on offspring health by obesity during pregnancy
has come from the study of siblings whowere born before
and after their mother had bariatric surgery to reduce her
adiposity. These have shown that siblings born postsur-
gery are leaner, more insulin sensitive and have lower
blood pressure than their sibling born before maternal
surgery and hence when the mother was obese (8–10).
These observational studies in humans suggesting that an
obesogenic in utero environment has programming effects
on the offspring have been supported by studies in animal
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models. Numerous studies in animals have shown that
there is a causal relationship between maternal overnutri-
tion during pregnancy and offspring obesity, insulin re-
sistance, fatty liver, andmetabolic syndrome (11–13).We
and others have shown that these programmed effects on
metabolism are associated with mitochondrial dysfunc-
tion and altered expression of insulin signaling proteins in
skeletal muscle and liver (14–16).
Adipose tissue is known to play an important role in the
developmentofmetabolic syndrome. It plays apivotal role
in maintaining metabolic homeostasis through its ability
to store and release lipids, take up glucose in an insulin-
responsive manner, and through the production of adipo-
kines (17,18). It hasbeendemonstrated that adipose tissue
is vulnerable to the effects of a suboptimal early environ-
ment and therefore can contribute to the programming of
whole-bodymetabolic dysfunction.Molecular analyses that
have adopted a candidate approach have demonstrated that
diet-induced obesity during pregnancy can lead to pro-
grammedeffects onmRNA,microRNA(miRNA), andpro-
tein expression in adipose tissue. These include studies that
have shown significant reduction in expression of glucose
transporter type 4 in adipose tissue, which can selectively
cause insulin resistance (19), and our own studies, which
demonstrate up-regulation of miR-126 that can directly in-
fluence insulin receptor substrate-1 protein expression (20).
The aim of the current study was to take an unbiased
approach to detect programmed changes in mRNA and
miRNA levels in adipose tissue that could contribute to
offspring metabolic dysfunction in later life. To achieve
this we carried out mRNA and miRNA array analyses on
adipose tissue from the male offspring of obese mouse
dams. We studied offspring in young adult life when they
were lean to enableus to identifydriversofpotential future
metabolic dysfunction rather than changes that were a
consequence of alterations in current adiposity.
Materials and Methods
Animal model
All studies were approved by the local Ethics Committee and
were conducted according to the Home Office Animals (Scien-
tific Procedures) Act 1986. The model of maternal diet-induced
obesity used here has been described previously (20). Briefly,
female C57BL/6J mice were fed ad libitum a standard control
chow diet (2.56 kcal/g; fat, 7.42% [kcal]; RM1, Special Diet
Services) or a highly palatable energy-rich obesogenic diet (6.79
kcal/g; fat, 45% [kcal]; 45%AFE Fat, Special Diet Services) and
sweetened condensed milk (55% simple sugar, 8% fat, 8% pro-
tein [wt/wt]; Nestle, fortified with mineral and vitamin mix
AIN93G) from 4 weeks of age. After 6 weeks on control or
obesogenic diets, dams (n  11 per group) were mated with
chow-fed males for first pregnancy. The dams were allowed to
litter, and the first litter was culled after weaning. This first preg-
nancy ensured themicewere proven breeders. After aweek,mice
weremated for a second pregnancy, and day 1 of pregnancy was
defined by the appearance of a plug. Dams were maintained on
their respective experimental diets throughout both pregnancy
and lactation. Litter sizes were standardized to 3 males and 3
females on postnatal day 3.Maternal body weight was recorded
on a weekly basis until weaning, at which time domain nuclear
magnetic resonance was performed before damswere culled. All
offspring groups were weaned onto standard chow (RM1), fed
ad libitum, at 21 days of age, and were maintained on this diet
for the remainder of the study. At 8 weeks of age, following an
overnight fast, offspring were killed by rising CO2 concentra-
tion. Epididymal adipose tissue was dissected, weighed, snap
frozen, and stored at80°C until use. Only male offspring were
assessed in this study inorder to control formetabolic differences
which could be influenced by the sex hormones.
RNA extraction for microarray analyses
Eachadipose tissue sampleused for themicroarrays consistedof
grounded,pooledadiposetissuefrom2litters (eachlitterhad3male
mice, therefore each microarray sample was a pool of a total of 6
mice). RNA was extracted from 50 mg of pooled adipose tissue
using a column basedmirVana isolation kit according to the man-
ufacturer’sprotocol.ForquantitativePCRanalysis (qPCR)analysis
for validationof themicroarrays, additionalRNAfromepididymal
adipose tissue was extracted from 1male adipose tissue from indi-
vidual litters (n 5 samples per group, where each n was adipose
tissue from 1 mouse from a single litter).
Microarray analysis
All reagents for the microarray analysis were purchased from
Agilent Technologies. mRNA expression profiling (n  4 pooled
samples per group) was performed using single-color Agilent Sure-
Print G3 Mouse GE 8 60KMicroarrays (design ID, 028005).
Data analysis was performed using GeneSpring GX 12.5
(Agilent). Intensities were normalized to the 75th percentile, and
baseline data transformationwasperformed to themedianof the
control samples. A P .05 was applied with a 2-fold change cut
off. Pathway analysis was then carried out using Ingenuity Path-
way Analysis (IPA) software. The pathway analysis identified
canonical pathways from the IPA library that were most signif-
icant to the dataset.
microRNA array analysis
miRNA expression profiling (n  5 pooled samples per
group) was performed using Agilent SurePrint Mouse mi-
croRNAMicroarray slides (design ID, 046065). The data were
extracted using the Agilent Feature Extraction software version
10.7.3.1 and analyzed using GeneSpring GX software. Intensi-
ties were normalized to the 90th percentile using the percentile
shiftmethod. Fold changeswere generated for samples expressed
above threshold levels and analyzed using unpaired Student’s t
test for significance (P  .05).
Putative targets of miR-706 and miR-3472 were scanned us-
ing the microRNA database miRWalk (21). Predicted 3-un-
translated region (UTR) target binding sites for miR-706 were
compared across 4 target prediction databases: miRanda,
miRDB, miRWalk, and TargetScan. A total of 168 targets were
commonly identified across databases. A similar comparison
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was not available for miR-3472, due to the lack of character-
ization of this relatively newly identified miRNA. Putative miR-
706 targets were then crosschecked with the transcript list gen-
erated from the microarray to determine whether putative miR-
706 targets were dys-regulated in maternal obese (Mat-Ob)
offspring adipose tissue.
Quantitative PCR analysis
The top 5 up-regulated and 5 down-regulated transcripts, iden-
tified by the microarray analysis, were selected for validation by
qPCR using the same samples of pooled adipose tissue that were
included in the array plus additional adipose tissue samples from a
single male mouse from different litters (n  8–11 per group) as
previously described (22). For primer sequences, see Supplemental
Table 1. mRNA expression was normalized to the geomean of the
housekeeping genes -actin, Gapdh, and Ppia, the expressions of
which did not differ between experimental groups.
miRNAs identified as significantly different between groups
were validated by TaqMan miRNA assay (Applied Biosystems)
for the miRNAs which had TaqMan assays available: mmu-let-
7c-1-3p (assay ID, 002479), mmu-mir-706 (assay ID, 001641),
and mmu-mir-3472 (assay ID, 241380_mat). miRNA expres-
sion was normalized to the geomean of the housekeepers
rnu6b_2, rnu5a, rnu1a, snord25, and scarna17 (QIAGEN
miScript primer control set catalog 218300), the expressions of
which did not change between the experimental groups.
Protein quantification
Putative miRNA targets were validated by Western blotting.
Protein was extracted from 50 mg of epididymal adipose tissue.
Protein lysates were standardized to a concentration of 1mg/mL
and 20-L total protein was resolved using SDS-PAGE (10%).
Calcium/calmodulin-dependent protein kinase 1D (CAMK1D)
primary antibody was diluted 1:10 000 in 5% BSA, 1 Tris-
buffered saline, 0.1%Tween 20 (ab172618; Abcam). IL-33 pri-
mary antibodywas diluted 1:500 in 1%nonfat dehydratedmilk,
1 Tris-buffered saline, 0.1% Tween 20 (sc-98660; Santa Cruz
Biotechnology). Horseradish peroxidase-conjugated secondary
antibodies (antirabbit/mouse/goat antibody; Jackson Immu-
noResearch) were used. Protein expression was quantified by
densitometry using AlphaEase software (AlphaInnotech).
Adipose tissue histology
Epididymal adipose tissue was fixed and paraffin embedded,
and25-msectionsper samplen5–6per groupweremounted
onto a positively charged slide. For adipocyte size and number
analysis, tissue was stained with hematoxylin and eosin following
a standard protocol. Automated analysis was performed using cell
P software. Macrophage and T-cell infiltration in the adipose sec-
tions was assessed using an antibody specific to macrophages (F4/
80) andTcells (CD3), followinga standardprotocol. Inbrief, slides
were rehydrated, treated with proteinase K, and incubated with
0.3% hydrogen peroxidase. Samples were treated with blocking
solution and then incubated with primary antibody F4/80 (Bio-
Rad) or CD3 (Abcam) at 4°C overnight. Secondary antirat IgG
antibody (Jackson ImmunoResearch) for F4/80 and antirabbit IgG
antibody (Dako) for CD3 was used. Macrophage number and T-
cell number were counted blindly in 10 fields of view per section at
20 magnification, using ImageJ analysis software.
Luciferase assay
Luciferase reporter constructs were generated by subcloning
either the IL-33-3-UTR target sequence of miR-706 or a mu-
tated IL-33-3-UTR target sequence downstream of the lu-
ciferase gene in a pGL3-control vector (Promega). HeLa cells
were seeded in 24-well plates at a density of 5  104 cells/well.
After 24 hours, cells were transfected with 100 ng of the firefly-
luciferase pGL3 construct (containing either the wild-type or the
mutated target sequence), plus 10 ng ofRenilla-luciferase pRL-TK
(Promega) used for normalization of the firefly luciferase activity
using Lipofectamine 2000 transfection reagent (Invitrogen). Cells
were cotransfectedwith 10nMmmu-miR-706mimic or a negative
control RNA (Life Technologies). Cells were harvested and lysed
after24hoursof transfectionandboth fireflyandRenilla-luciferase
activity was measured using a DualGlo Luciferase Assay System
(Promega). Luciferase activity in lysates of cells transfectedwith the
mmu-miR-706mimicwas normalized by the signal acquired in the
respective negative control transfection.
Statistical analysis
In each case, n refers to the number of adipose tissue samples
per group. Formicroarray data, each nwas a pool of 6mice from
2 litters. For all other data, n refers to the number of mice from
different litters. For normally distributed data, results are shown
as mean  SEM, and data were analyzed using unpaired Stu-
dent’s t tests.Data that didnot pass the normality tests are shown
as median with interquartile range (IQR) and were analyzed by
the Mann Whitney U test. For all data, P  .05 was considered
statistically significant.
Results
Maternal body weight and composition
Feeding dams an obesogenic diet resulted in signifi-
cantly increased body weight at the start of pregnancy
Table 1. Body Weights of Control and Diet-Induced
Obese Dams Throughout Pregnancy and Lactation
Body Weight (g)
Control
Dams
Obese
Dams
Pregnancy day 2 28.4  0.7 34.1  2.4a
Lactation day 2 32.2  0.4 35.0  1.1a
Lactation day 21 33.5  0.5 40.2  2.3b
n  11 per group, values presented as mean  SEM.
a P  .05.
b P  .01.
Table 2. Body Composition of Control and
Diet-Induced Obese Dams at the End of Lactation
Control
Dams
Obese
Dams
Lean mass (g) 19.6  0.3 19.7  0.3
% Lean mass 72.1  0.6 55.9  2.7a
Fat mass (g) 3.1  0.3 12.9  2.0a
% Fat mass 11.3  0.7 33.7  3.3a
n  11 per group, values presented as mean  SEM.
a P  .001.
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compared with mice fed a control diet. This was main-
tained throughout pregnancy and lactation (Table 1), sim-
ilar to findings previously published (23). Body composi-
tion of the dams analyzed at the end of lactation showed
that dams fed the obesogenic diet had significantly higher
body fat mass, both in absolute terms and as a percentage
of body weight. Lean mass in relative terms was reduced
but unchanged in absolute terms (Table 2).
Offspring whole-body phenotype
As expected, based on previous studies, there were no
differences in body weight (Figure 1) or adiposity (relative
total [epididymal, retroperitoneal, and ip] fat pad weight
control, 13.4 1.05-mg/g body weight vs Mat-Ob 13.5
1.06-mg/g body weight) between the groups at 8 weeks.
Therewere also nodifferences in fasted levels of plasma trig-
lycerides (control, 1.5 mmol/L [IQR, 1.2–2.3] vs Mat-Ob,
1.4 mmol/L [IQR, 1.0–1.6]), cholesterol (control, 3.22 
0.11 mmol/L vs Mat-Ob, 3.33  0.09 mmol/L) or glucose
(control, 6.5 0.8mmol/L vsMat-Ob, 6.2 0.4mmol/L).
This therefore confirmed that any differences that we iden-
tified in gene expression profile in adipose tissue were not
related to any changes in adiposity or circulating lipid levels.
Global gene expression identifies up-regulated
inflammatory profile
Microarray analysis was performed to detect global
changes and patterns in mRNA content in response to the
exposure to maternal obesity in early life. The microarray
contained 55 821 probes, representing 39 430 Entrez
Figure 1. Offspring phenotype at 8 weeks of age. Postweaning body
weight trajectory; *, P  .05, n  11 per group.
Figure 2. Adipose microarray analysis. qPCR validation of top up-regulated (A) and down-regulated (B) transcripts; gene categories significantly enriched
with up-regulated (C) and down-regulated (D) transcripts. qPCR expression was normalized to the geometric mean of the housekeepers -actin, gapdh,
and ppia. *, P .05; **, P .01; ***, P .001 determined by one-tailed Student’s t test, n 10 for control, n 11 for Mat-Ob.
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genes and 16 251 long noncoding RNAs. After the re-
moval of long noncoding RNAs, predicted/unannotated
genes, and pseudo/chromosomal genes from the analysis,
a total of 14 601 transcripts (37%of those represented on
the array) were expressed above threshold levels in off-
spring adipose tissue at 8 weeks of age. A total of 178
transcripts in offspring adipose tissue were significantly
(P  .05) differentially expressed by greater than 2-fold
after exposure tomaternal diet-induced obesity. A total of
122 gene transcripts were significantly up-regulated, and
53 gene transcripts were significantly down-regulated in
8-week-old Mat-Ob offspring epididymal adipose tissue
compared with controls (full list of transcripts in Supple-
mental Tables 2 and 3). Differential expression of 9 of the
10 transcripts (90%) chosen for validationwas confirmed
by qPCR (Figure 2, A and B).
IPA identified gene function categories and signaling
pathways that were significantly populated with tran-
scripts from themicroarray analysis. In total, 28pathways
were enriched with up-regulated transcripts (Supplemen-
tal Table 4). These included genes involved in inflamma-
tory response, immune cell trafficking, and cell-mediated
immune responses (Il1,Tnf,Ccl2, andCcl7) (Figure 2C
and Supplemental Table 4). Thirty-eight pathways were
enrichedwith down-regulated transcripts. These included
genes involved in lipid and carbohydratemetabolism (Fig-
ure 2D and Supplemental Table 5).
Because obesity is considered a chronic inflammatory
disease, and inflammatory chemokines and transcription
factors were identified in the microarray, we further pro-
filed the expression of chemokines and transcription fac-
tors involved in inflammatory cell recruitment that have
been reported as up-regulated in obese individuals. None
of these additional chemokines or inflammatory tran-
scription factorswere found tobe up-regulated inMat-Ob
offspring just the Ccl2, Ccl7, and Tnf identified in the
microarray (Figure 3, A and B), suggesting these genes are
selectively sensitive to programming. In addition, circu-
lating levels and epididymal fat pad expression of leptin
were significantly elevated inMat-Oboffspring at 8weeks
of age (P  .016 and P  .018, respectively) (Table 3).
Hypertrophied adipose tissue
In light of the data described above, we further exam-
ined adipose tissue to determine whether up-regulated
leptin,Ccl2,Ccl7, andTnf could result in localizedmac-
rophage recruitment/infiltration.
We examined the expression of macrophage markers
by qPCR and detected no significant differences in their
expression between the 2 groups (Figure 4A). We also
stained adipose tissue sections with F4/80 to detect pos-
sible subtle changes in macrophage numbers in offspring
adipose tissue. However, there was no change in the num-
berofmacrophagesobservedwithin theMat-Oboffspring
adipose tissue compared with control (Figure 4B). In ad-
dition, there was no detectable infiltration of T cells in the
adipose tissue (data not shown). Adipose tissue histology
showed that adipocytes in Mat-Ob offspring were signif-
icantly larger in size (control, 682 m2 [787–829 m2
95% confidence interval] and Mat-Ob, 898 m2 [1024–
1087 m2 95% confidence interval] values represent me-
dian; P  .001); hence, there were fewer in number, per
field of view, when compared with control offspring (Fig-
ure 5, A–D).
Global microRNA expression
miRNA mediated regulation of gene expression at the
translation stage may be a potential mechanism underly-
Table 3. Leptin Expression at 8 Weeks of Age
Control Mat-Ob
Serum leptin (pg/mL) 523  122 1035  142a
Adipose tissue leptin
mRNA expression
4.08  0.6 16.44  4.24a
Values presented as mean  SEM or median (IQR).
a P  .05 determined by 2-tailed Student’s t test, n  8 per group.
Figure 3. Inflammation in 8-week-old male adipose tissue. A,
Chemokine expression. B, Inflammatory transcription factor expression
at mRNA level. qPCR expression was normalized to the geomean of
the housekeepers -actin, gapdh, and ppia. *, P  .05; **, P  .01;
***, P  .001 determined by 2-tailed Student’s t test, n  10 for
control, n  11 for Mat-Ob.
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ing developmental programming. We profiled the global
expression of miRNAs using a microarray platform. The
microarray represented1247uniquemousemiRNAs, cor-
responding to miRBase v.17.0. A total of 1090 miRNAs
were detected in mouse adipose tissue above background
levels, representing 87% expression of those represented.
Of these, 4 miRNAs were significantly differentially ex-
pressed (P  .05) in Mat-Ob compared with controls
(Table 4). A significant down-regulation of miR-706 and
miR-3472 was confirmed inMat-Ob offspring; there was
no significant difference let-7c-1-3p between the 2 groups
(Figure 6A). Of these 2 validated targets, we focused our
studiesonmiR-706,becausedetailed informationonmiR-
3472 and its targets was not available at the time of anal-
ysis. We searched for potential miR-706 targets using the
miRWalkmiRNAdatabase, as described inMaterials and
Methods. Our search identified 2 putative targets related
to inflammation: CAMK1D and IL-33.
microRNA inflammation pathway target analysis
Transcript levels of CAMK1D and IL-33 were not up-
regulated in the microarray analysis. However, miRNAs
are thought to act posttranscriptionally through regula-
tion of translation, so protein expression levels of these 2
genes were determined. CAMK1D levels were signifi-
cantly (P  .001) elevated by 30% in the Mat-Ob off-
spring (Figure 6B). IL-33 protein levels were also signifi-
cantly (P  .05) increased by 41% in Mat-Ob offspring
compared with controls at 8 weeks of age (Figure 6C).
miR-706 lies within intron 1 of its host gene WNK
lysine-deficient protein kinase 1 (Wnk1). The expression
ofWnk1 did not differ between the 2 experimental groups
(Figure 6D), suggesting miR-706 is regulated indepen-
dently of its host in this model.
We then used a luciferase reporter system to show that
there was a direct interaction between miR-706 and its
putative target sequence within the 3-UTR of IL-33.
HeLa cells were transfected with lu-
ciferase constructs containing the
target sequence for miR-706 in the
3-UTR (Figure 6E). Upon exposure
to miR-706 mimetic, cells bearing
the IL-33 constructs showed an in-
hibition in luciferase activity. The
specificity of the effect was con-
firmed by using amutated version of
the binding site within the 3-UTR
(Figure 6F).
Discussion
In this study,weused a genome-wide
approach to profile adipose tissue
transcription and miRNA expres-
sion in 8-week-oldmice offspring af-
Figure 5. Adipose tissue histology in 8-week-old males. A, Adipocyte cell size analysis. B,
Adipocyte cell number. Representative images of hemotoxylin stained adipocytes from control (C)
and Mat-Ob (D) groups. Scale bar, 75 m.
Figure 4. Inflammatory cell markers in 8-week-old male epididymal adipose tissue. A, qPCR expression of classical inflammatory cell markers,
normalized to the geomean of the housekeeping genes -actin, gapdh, and ppia (n  10 for control, n  11 for Mat-Ob). B, Average
macrophage cell count per field of view (n  5 for control, n  6 for Mat-Ob).
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ter exposure to maternal diet-induced obesity during ges-
tation and lactation. Offspring were fed a control diet
from weaning and studied at 8 weeks of age in order to
determine potential underlying mechanisms that may in-
fluence offspring risk of metabolic disorder independent
of differences in total adiposity between the 2 groups. As
adipose tissue is considered to be an endocrine organ as
well as the primary site of lipid storage in the body, dys-
regulated gene expression can potentially impact on
whole-body metabolism.
This study identified many genes in the microarray
which were both up and down-regulated across different
pathways.Many of these pathways are interesting such as
cell proliferation and development, which could have a
significant impact on themetabolic phenotype seen in this
model. For this study, inflammation became themain area
of focus, because this category had the most up-regulated
pathways associated with it. Inflammatory response, im-
mune cell trafficking, and cell-mediated immune re-
sponses were all up-regulated in the Mat-Ob group.
Our approach revealed significant alterations in
Mat-Ob offspring adipose tissue gene expression, with an
up-regulation of genes involved in cytokine signaling, in-
flammatory response, and development. Obesity has long
been recognized as a chronic low-grade inflammatory dis-
ease. However, in the current study, we observe a proin-
flammatory profile in offspring from obese dams that
precedes differences in adiposity. Adipose tissue inflam-
mation in obese subjects, both in mice and humans, has
been associated with insulin resistance. Studies have dem-
onstrated an increased inflammatory profile in rodent
models before the onset of impaired insulin resistance.
High-fat diet (HFD)-fed mice, for example, showed in-
creased inflammation specifically in adipose tissue after
only 3 weeks feeding on such a diet (24). In the current
study, this increased inflammation is observed in animals
fed a chow diet. TNF, a proinflammatory cytokine, has
been shown todirectlymediate insulin resistance in rodent
models of obesity (25). Previous studies on fetal adipose
tissue from 60%HFD-fed mice dams showed that TNF
is increased in fetal adipose tissue as an immediate con-
sequence of maternal high-fat feeding (19). We observed
TNF to be increased in the adipose tissue from offspring
of obese dams in adulthood demonstrating that the in-
creasemay be programmed andpresent beyond the period
of exposure to the obesogenic environment. Therefore,
these findings suggest that programming of an early in-
flammatory adipose tissue phenotype may be a mecha-
nism that underlies the development of metabolic disor-
ders as a consequence of maternal obesity.
Chemokines play an important role during inflamma-
tion, because their purpose is to regulate cell trafficking.
Both chemokine C-C-motif chemokine ligand 2 (CCL2)
and CCL7 expression was significantly higher in adipose
tissue from the offspring of obese dams. CCL2, which is
also known as monocyte chemoattractant protein-1, acts
through promoting infiltration of macrophages and re-
cruiting monocytes and other inflammatory cell markers
(26,27).CCL7, alsoknownasmonocyte chemotactic pro-
tein-3, plays a role in chemotaxis ofmonocytes (28).These
2 chemokines were increased as an immediate conse-
quence of maternal high-fat feeding (29). Our findings
demonstrate that their increase may be programmed in
adipose tissue as a consequence of maternal diet-induced
obesity and is retained after the period of exposure. In hu-
mans, CCL2 andCCL7have been shown to be important in
orchestrating the migration of many immune cells such as
T-cells and natural killer cells to the area of inflammation
(30, 31). In the current study, we were not able to show
alterations in macrophage infiltration in adipose tissue at 8
weeks of age. This is consistent with this time point being an
early stage of the inflammatory process, which is likely to
increase with age and as the animal becomes obese.
An important aspect of our findings was that the adi-
pose tissue inflammationoccurredbefore anydifference in
adiposity. Although adiposity was not different between
offspring groups, Mat-Ob fat depots contained a higher
proportion of larger adipocytes than the controls. In ad-
dition, we demonstrated that the offspring from Mat-Ob
had higher leptin mRNA levels in their adipose tissue and
increased serum leptin levels. This is consistent with pre-
vious studies suggesting that larger adipocytes express
higher levels of leptin (32, 33). This hyperleptinemia may
significantly impact on the triglyceride storage capacity of
the mature adipocytes in the Mat-Ob group, which may
further contribute to the inflammatory state. A number of
studies suggest that the expansion of visceral fat stores, as
seen here, also leads to the increasing levels of reactive
oxygen species that can stimulate production of inflam-
matory cytokines.
Our genome-wide miRNA profiling revealed differen-
tial expression of only a very small number of miRNAs
represented on the array (0.32%). It is not clear if the low
number identified is a reflection of low sensitivity of the
methodology for miRNA analysis or a reflection that very
Table 4. miRNAs Differentially Regulated in
8-Week-Old Male Offspring
microRNA P Value Fold Change
let-7c-1-3p .0026 1.66
miR-706 .0085 1.42
miR-3472 .0403 1.53
miR-324-3p .0406 1.10
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fewmiRNAs are differentially expressed in adipose tissue
from the offspring of obese dams comparedwith controls.
There are very fewgenome-widemiRNA-profiling studies
in maternal programming models; however, the few stud-
ies performed to date using the same methodology have
also demonstrated a low number of differentially ex-
pressed miRNAs. The hepatic expression of approxi-
mately 5.7%of 579miRNAsmeasuredwere altered in the
offspring of HFD-fed dams at 15 weeks of age and the
majority (4%) were found to be down-regulated (34).
Many of themiRNAs identified had common targets, sug-
gesting that regulation of specific genes might be coordi-
nated by a small number of miRNAs. In addition, in an
ovine model of maternal obesity, fetal skeletal muscle ex-
pressed 155 of the tested miRNAs, of which only 3 were
differentially regulated in response to maternal obesity
Figure 6. microRNA and putative target validation. A, qPCR validation of selected miRNA from the microarray, normalized to the geomean of the
housekeepers rnu6b_2, rnu5a, rnu1a, snord25, and scarna17 (n  10 and 11 for control and Mat-Ob, respectively). B, Protein levels of CAMK1D
determined by Western blotting with representative blots (n  8 per group). C, Protein levels of IL-33 determined by Western blotting with
representative blots (n  8 per group). D, mRNA levels of Wnk1 (n  10 per group). E, Target sequence and mutated target sequence of miR-706
on IL-33 3-UTR subcloned in a pGL3-enhancer vector (pGL3-IL33 3-UTR-wt and pGL3-IL-33 3-UTR-mut, respectively). F, Normalized luciferase
activity of the wild-type (pGL3-IL-33 3-UTR-wt) and mutant (pGL3-IL33 3-UTR-mut) IL-33 3-UTR/miR-706 binding site in HeLa cells after negative
control (NC) or miR-706 mimic transfection (n  6 per group); *, P  .05; **, P  .01; ***, P  .001.
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exposure (35). The advancement in technology and the cur-
rent availability of deep sequencing technology to assess
miRNA expression will help address this question as to
whether the small number of programmed miRNAs identi-
fied reflects limitations in previous technology or biology.
Of the programmed miRNAs identified in this study,
wedemonstrated thatmiR-706hadbiological actions that
were consistent with a programmed inflammatory phe-
notype. Because miRNAs generally function to repress
protein expression, we expected an increased translation
of their target mRNAs. This was indeed the case for 2
putative targets ofmiR-706:CAMK1Dand IL-33, bothof
which are involved in inflammatory signaling and were
found to be significantly elevated at the protein level in
adipose tissue from programmed offspring. IL-33 is re-
quired for the homeostasis of immune cell regulation, par-
ticularly T regulatory cells. IL-33-deficient mice show sig-
nificant reduction in T regulatory cells in visceral adipose
tissue, a traitwhich suggests that IL-33 plays an important
role in maintaining cell homeostasis (36). Elevation of IL-
33, as seen here, has been shown to induce production of
Th2 cytokines such as IL-5 and IL-13, decrease lipid stor-
age, and alter expression of genes associated with lipid
metabolism (37). This process may be an attempt by the
adipose tissue to try and restrict lipid accumulation and,
thus, restoring functionality in the tissue. CAMK1D is
currently not well characterized in terms of biological
function, however, as well as being involved in inflamma-
tory signaling, evidence from the liver suggests that it is
important for glucose metabolism (38). The impact of in-
creased of CAMK1D and IL-33 expression on adipocytes
warrants further investigation. The data from the current
study suggest a mechanistic role for miR-706 in contrib-
uting to the inflammation in adipose tissue programmed
by maternal obesity. The complete spectrum of targets of
miR-706 in adipose tissue and the phenotype conse-
quences of its dysregulation are unknown. Because
miRNAs often act through regulation of translation, this
would require detailed proteomic analysis.
In conclusion, our genome-wide approach has identi-
fied potentialmechanismsunderlying the programmingof
metabolic disease through maternal obesity. We provide
evidence that in response to external stimuli, such as ma-
ternal diet-induced obesity, the adipose tissue transcrip-
tome of the resulting offspring, when fed a control diet, is
dynamically regulated. We demonstrated an elevation in
inflammatory signaling at 8 weeks of age, independent of
offspring adiposity that was accompanied by a larger adi-
pocyte cell size. miRNAs, although less widely affected,
also contributed to the posttranscriptional regulation of
expression of inflammatory signaling molecules. We pos-
tulate that this inflammation may contribute to the un-
derlyingmechanisms resulting inmetabolic dysfunctionas
a consequence of maternal obesity.
Appendix
Table 5. Antibody Table
Peptide/
Protein
Target
Antigen Sequence
(if Known)
Name of
Antibody
Manufacturer, Catalog
Number, and/or Name
of Individual
Providing the
Antibody
Species Raised in;
Monoclonal or
Polyclonal
Dilution
Used
CAMK1D Anti-CAMK1D Abcam, ab172618 Rabbit; monoclonal
[EPR3536 (2)]
1:10 000
IL-33 MRPRMKYSNSKISPAKFSST
AGEALVPPCKIRRSQQKTK
EFCHVYCMRLRSGLTIRKET
SYFRKEPTKRYSLKSGTKH
EENFSAYPRDSRKRSLLGSI
QAFAASVDTLSIQGTSLLTQ
SPASLSTYNDQSVSFVLENG
CYVINVDDSGKDQEQDQVLL
RYYESPCPASQSGDGVDGKK
LMVNMSPIKDTDIWLHANDK
DYSVELQRGDVSPPEQAFFV
LHKKSSDFVSFECKNLPGTY
IGVKDNQLALVEEKDESCNN
IMFKLSK
IL-33 Santa Cruz Biotechnology,
sc-98660
Rabbit; polyclonal
(M-226)
1:500
CD3 KAKAKPVTRGAGA Anti-CD3 antibody
[SP7]
Abcam, ab16669 Rabbit; monoclonal
[SP7]
1:1000 for WB
1:100 for IHC
F4/80 F4/80 antibody Bio-Rad, MCA497G Rat; monoclonal 1:150
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